epocrates logo
epocrates logo
epocrates logo
  • 0

Tables

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account
Browse:
Tables

Dietary Reference Intakes: Potassium

(Food and Nutrition Board, NAM; NIH Office of Dietary Supplements)

Special Note

[recommendations reflect elemental potassium intake from all sources]

General Information

[salt form conversion]
500 mg potassium gluconate = 83.5 mg (2.14 mEq) elemental potassium
[primary functions]
maintains intracellular fluid volume, transmembrane electrochemical gradients
[selected sources]
fruits, vegetables, legumes, dairy, nuts, meat

Dietary Reference Intake

[0-6 mo]
400 mg/day; Info: upper limit not established; only sources of intake should be breastmilk, formula, and food
[7-11 mo]
860 mg/day; Info: upper limit not established; only sources of intake should be breastmilk, formula, and food
[1-3 yo]
2000 mg/day; Info: upper limit not established, potential for adverse effects with high supplement intake
[4-8 yo]
2300 mg/day; Info: upper limit not established, potential for adverse effects with high supplement intake
[9-18 yo, females]
2300 mg/day; Info: incr. to 2600 mg/day if pregnant, 2500 mg/day if breastfeeding; upper limit not established, potential for adverse effects with high supplement intake
[9-13 yo, males]
2500 mg/day; Info: upper limit not established, potential for adverse effects with high supplement intake
[14-18 yo, males]
3000 mg/day; Info: upper limit not established, potential for adverse effects with high supplement intake
[19 yo and older, females]
2600 mg/day; Info: incr. to 2900 mg/day if pregnant, 2800 mg/day if breastfeeding; upper limit not established, potential for adverse effects with high supplement intake
[19 yo and older, males]
3400 mg/day; Info: upper limit not established, potential for adverse effects with high supplement intake
Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information